Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: Triamcinolone Acetonide Injection for Upper Eyelid Retraction in Thyroid Eye Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating Triamcinolone Acetonide Injection for upper eyelid retraction in Thyroid Eye Disease. The study was sponsored by Instituto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone Acetonide Injection (triamcinolone acetonide)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Thyroid Eye Disease, TED | NA | Status: COMPLETED